As of 2025-10-29, the EV/EBITDA ratio of AnaptysBio Inc (ANAB) is -6.43. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AnaptysBio's latest enterprise value is 968.18 mil USD. AnaptysBio's TTM EBITDA according to its financial statements is -150.59 mil USD. Dividing these 2 quantities gives us the above AnaptysBio EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 14.4x | 11.1x |
| Forward P/E multiples | 15.8x - 19.8x | 18.6x |
| Fair Price | (83.40) - (75.76) | (78.29) |
| Upside | -330.6% - -309.5% | -316.5% |
| Date | EV/EBITDA |
| 2025-10-24 | -6.23 |
| 2025-10-23 | -6.03 |
| 2025-10-22 | -5.96 |
| 2025-10-21 | -6.05 |
| 2025-10-20 | -6.27 |
| 2025-10-17 | -6.14 |
| 2025-10-16 | -6.10 |
| 2025-10-15 | -6.08 |
| 2025-10-14 | -5.63 |
| 2025-10-13 | -5.74 |
| 2025-10-10 | -5.54 |
| 2025-10-09 | -5.61 |
| 2025-10-08 | -5.62 |
| 2025-10-07 | -5.26 |
| 2025-10-06 | -5.33 |
| 2025-10-03 | -5.46 |
| 2025-10-02 | -5.53 |
| 2025-10-01 | -5.65 |
| 2025-09-30 | -5.40 |
| 2025-09-29 | -4.03 |
| 2025-09-26 | -4.09 |
| 2025-09-25 | -3.80 |
| 2025-09-24 | -3.82 |
| 2025-09-23 | -3.60 |
| 2025-09-22 | -3.68 |
| 2025-09-19 | -3.58 |
| 2025-09-18 | -3.63 |
| 2025-09-17 | -3.39 |
| 2025-09-16 | -3.31 |
| 2025-09-15 | -3.45 |
| 2025-09-12 | -4.06 |
| 2025-09-11 | -4.02 |
| 2025-09-10 | -3.94 |
| 2025-09-09 | -3.82 |
| 2025-09-08 | -3.83 |
| 2025-09-05 | -3.78 |
| 2025-09-04 | -3.63 |
| 2025-09-03 | -3.89 |
| 2025-09-02 | -3.54 |
| 2025-08-29 | -3.49 |
| 2025-08-28 | -3.45 |
| 2025-08-27 | -3.50 |
| 2025-08-26 | -3.42 |
| 2025-08-25 | -3.44 |
| 2025-08-22 | -3.47 |
| 2025-08-21 | -3.49 |
| 2025-08-20 | -3.45 |
| 2025-08-19 | -3.39 |
| 2025-08-18 | -3.43 |
| 2025-08-15 | -3.45 |